I received my B.A. in Psychology from D'Youville College in Buffalo, NY and I received my graduate degrees in Clinical Psychology from the University at Buffalo, in Buffalo, NY. I completed my pre-doctoral clinical residency and postdoctoral training with Western Psychiatric Hospital (formerly Western Psychiatric Institute and Clinic) and the University of Pittsburgh Department of Psychiatry. I began teaching at Westminster in 2016. My teaching areas include Abnormal Psychology, Psychological Assessment, Clinical Psychology, Psychology of Sex, Personality, and Introduction to Psychology. My specific research interests focus on the underlying cognitive, behavioral, and motivational factors associated with cigarette smoking and Attention-Deficit/Hyperactivity Disorder (ADHD). I am currently collaborating with Dr. Helen Boylan on a research study investigating the effects of nature therapy on affective and cognitive functioning. Outside of the classroom and research lab, I am also a licensed Clinical Psychologist. I provide intervention and assessment services for individuals across the lifespan with many forms of psychopathology. In my non-Westminster time, I enjoy going on adventures with my husband and three children.
Rhodes, J.D. (2023). An Examination of the Role of Sluggish Cognitive Tempo as a Moderator of the Relationship Between ADHD and Nicotine Use. Journal of Attention Disorders. DOI: 10.1177/10870547221130454.
Rhodes, J.D., Kennedy, T., Gnagy, E., Pelham, W.E., & Molina, B.S.G. (2021). Smoking-Specific Risk Factors in Early Adulthood that Mediate Risk of Daily Smoking by Age 29 for Children with ADHD. Journal of Attention Disorders. DOI: 10.1177/10870547211003664.
Rhodes, J.D., Pelham, W.E., Jr., Gnagy, E., Shiffman, S., Derefinko, K., Molina, B.S.G. (2016). Cigarette smoking and ADHD: An examination of prognostically-relevant smoking behaviors among adolescents and young adults. Psychology of Addictive Behaviors, 30(5), 588-600.
Rhodes, J.D. & Hawk, L.W., Jr. (2016). Smoke and mirrors: The overnight abstinence paradigm as an index of disrupted cognitive function. Psychopharmacology, 233(8), 1395-1404.